Rare illness treatment Glybera wins European drugs regulator's approval in 'watershed moment' The first gene therapy to treat a rare illness came closer to market today after the European drugs regulator recommended the medicine for approval across member states. The therapy, Glybera , is for patients with an unusual genetic disorder that means their bodies fail to make an enzyme that breaks ...

See the original post here:

West's first gene therapy gets closer to market